179 related articles for article (PubMed ID: 37729199)
1. HMGB1 released by mesothelial cells drives the development of asbestos-induced mesothelioma.
Suarez JS; Novelli F; Goto K; Ehara M; Steele M; Kim JH; Zolondick AA; Xue J; Xu R; Saito M; Pastorino S; Minaai M; Takanishi Y; Emi M; Pagano I; Wakeham A; Berger T; Pass HI; Gaudino G; Mak TW; Carbone M; Yang H
Proc Natl Acad Sci U S A; 2023 Sep; 120(39):e2307999120. PubMed ID: 37729199
[TBL] [Abstract][Full Text] [Related]
2. Asbestos induces mesothelial cell transformation via HMGB1-driven autophagy.
Xue J; Patergnani S; Giorgi C; Suarez J; Goto K; Bononi A; Tanji M; Novelli F; Pastorino S; Xu R; Caroccia N; Dogan AU; Pass HI; Tognon M; Pinton P; Gaudino G; Mak TW; Carbone M; Yang H
Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25543-25552. PubMed ID: 32999071
[TBL] [Abstract][Full Text] [Related]
3. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation.
Yang H; Rivera Z; Jube S; Nasu M; Bertino P; Goparaju C; Franzoso G; Lotze MT; Krausz T; Pass HI; Bianchi ME; Carbone M
Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12611-6. PubMed ID: 20616036
[TBL] [Abstract][Full Text] [Related]
4. Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches-a narrative review.
Zolondick AA; Gaudino G; Xue J; Pass HI; Carbone M; Yang H
Precis Cancer Med; 2021 Sep; 4():. PubMed ID: 35098108
[TBL] [Abstract][Full Text] [Related]
5. Synthetic Secoisolariciresinol Diglucoside (LGM2605) Prevents Asbestos-Induced Inflammation and Genotoxic Cell Damage in Human Mesothelial Cells.
Pietrofesa RA; Chatterjee S; Kadariya Y; Testa JR; Albelda SM; Christofidou-Solomidou M
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077483
[TBL] [Abstract][Full Text] [Related]
6. Preventive and therapeutic opportunities: targeting BAP1 and/or HMGB1 pathways to diminish the burden of mesothelioma.
Carbone M; Minaai M; Takinishi Y; Pagano I; Yang H
J Transl Med; 2023 Oct; 21(1):749. PubMed ID: 37880686
[TBL] [Abstract][Full Text] [Related]
7. BAP1 forms a trimer with HMGB1 and HDAC1 that modulates gene × environment interaction with asbestos.
Novelli F; Bononi A; Wang Q; Bai F; Patergnani S; Kricek F; Haglund E; Suarez JS; Tanji M; Xu R; Takanishi Y; Minaai M; Pastorino S; Morris P; Sakamoto G; Pass HI; Barbour H; Gaudino G; Giorgi C; Pinton P; Onuchic JN; Yang H; Carbone M
Proc Natl Acad Sci U S A; 2021 Nov; 118(48):. PubMed ID: 34815344
[TBL] [Abstract][Full Text] [Related]
8. Cancer-promoting role of adipocytes in asbestos-induced mesothelial carcinogenesis through dysregulated adipocytokine production.
Chew SH; Okazaki Y; Nagai H; Misawa N; Akatsuka S; Yamashita K; Jiang L; Yamashita Y; Noguchi M; Hosoda K; Sekido Y; Takahashi T; Toyokuni S
Carcinogenesis; 2014 Jan; 35(1):164-72. PubMed ID: 23917077
[TBL] [Abstract][Full Text] [Related]
9. Differential Susceptibility of Human Pleural and Peritoneal Mesothelial Cells to Asbestos Exposure.
Dragon J; Thompson J; MacPherson M; Shukla A
J Cell Biochem; 2015 Aug; 116(8):1540-52. PubMed ID: 25757056
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma.
Carbone M; Yang H
Clin Cancer Res; 2012 Feb; 18(3):598-604. PubMed ID: 22065079
[TBL] [Abstract][Full Text] [Related]
11. HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients.
Napolitano A; Antoine DJ; Pellegrini L; Baumann F; Pagano I; Pastorino S; Goparaju CM; Prokrym K; Canino C; Pass HI; Carbone M; Yang H
Clin Cancer Res; 2016 Jun; 22(12):3087-96. PubMed ID: 26733616
[TBL] [Abstract][Full Text] [Related]
12. HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma.
Wang Y; Jiang Z; Yan J; Ying S
Dis Markers; 2019; 2019():4183157. PubMed ID: 30891101
[TBL] [Abstract][Full Text] [Related]
13. Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-α signaling.
Qi F; Okimoto G; Jube S; Napolitano A; Pass HI; Laczko R; Demay RM; Khan G; Tiirikainen M; Rinaudo C; Croce A; Yang H; Gaudino G; Carbone M
Am J Pathol; 2013 Nov; 183(5):1654-66. PubMed ID: 24160326
[TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of mesothelioma.
Carbone M; Bedrossian CW
Semin Diagn Pathol; 2006 Feb; 23(1):56-60. PubMed ID: 17044196
[TBL] [Abstract][Full Text] [Related]
15. Inflammation as a chemoprevention target in asbestos-induced malignant mesothelioma.
Kadariya Y; Sementino E; Shrestha U; Gorman G; White JM; Ross EA; Clapper ML; Neamati N; Miller MS; Testa JR
Carcinogenesis; 2022 Dec; 43(12):1137-1148. PubMed ID: 36355620
[TBL] [Abstract][Full Text] [Related]
16. Serum HMGB1 as a diagnostic marker for malignant peritoneal mesothelioma.
Tabata C; Kanemura S; Tabata R; Masachika E; Shibata E; Otsuki T; Nishizaki T; Nakano T
J Clin Gastroenterol; 2013 Sep; 47(8):684-8. PubMed ID: 23685846
[TBL] [Abstract][Full Text] [Related]
17. Human mesothelioma cells and asbestos-exposed mesothelial cells are selectively resistant to amosite toxicity: a possible mechanism for tumor promotion by asbestos.
Gabrielson EW; Van der Meeren A; Reddel RR; Reddel H; Gerwin BI; Harris CC
Carcinogenesis; 1992 Aug; 13(8):1359-63. PubMed ID: 1323425
[TBL] [Abstract][Full Text] [Related]
18. Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.
Xu J; Kadariya Y; Cheung M; Pei J; Talarchek J; Sementino E; Tan Y; Menges CW; Cai KQ; Litwin S; Peng H; Karar J; Rauscher FJ; Testa JR
Cancer Res; 2014 Aug; 74(16):4388-97. PubMed ID: 24928783
[TBL] [Abstract][Full Text] [Related]
19. Iron addiction with ferroptosis-resistance in asbestos-induced mesothelial carcinogenesis: Toward the era of mesothelioma prevention.
Toyokuni S
Free Radic Biol Med; 2019 Mar; 133():206-215. PubMed ID: 30312759
[TBL] [Abstract][Full Text] [Related]
20. Global overexpression of divalent metal transporter 1 delays crocidolite-induced mesothelial carcinogenesis in male mice.
Funahashi S; Okazaki Y; Nishiyama T; Ohyoshi H; Yasui H; Nishida K; Matsui S; Toyokuni S
Free Radic Res; 2018 Sep; 52(9):1030-1039. PubMed ID: 30309285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
